Live influenza vaccine for children and adults: transmissibility in in vivo experiments


Cite item

Full Text

Abstract

erson-to-person transmission plays a key role in the spread of seasonal and pandemic strains. To unveil the mechanisms underlying the transmissibility will be able to more effectively control influenza and search for new ways and methods of its prevention. Today vaccination is the most effective method for influenza prophylaxis. Therefore whether live influenza vaccine strains can spread in the population through their further reassortment with circulating viruses is extremely important. This investigation on a model of guinea pigs has studied whether wild-type and cold-adapted influenza viruses can be transmitted to uninfected animals. Influenza H5N1 virus is shown to be a highly transmissible agent to not only contact animals, but also to those which are a considerable distance from them. There is evidence that there is interference of cold-adapted strains with wild-type viruses, which opens new prospects for the use of live influenza vaccine in the pandemic situation and confirms that it is groundless to fear (be concerned) about that mass vaccination of population with live attenuated influenza vaccine may lead to the generation of reassortant mutant viruses with higher pathogenicity level.

About the authors

Irina Anatol'evna Dubrovina

НИИ экспериментальной медицины СЗО РАМН

Email: ropsha.home@rambler.ru
мл. науч. сотр., отд. вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

Ekaterina Andreevna Bazhenova

НИИ экспериментальной медицины СЗО РАМН

Email: sonya.01.08@mail.ru
мл. науч. сотр., отд. вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

Irina Vasil'evna Kiseleva

НИИ экспериментальной медицины СЗО РАМН

Email: irina.v.kiseleva@mail.ru
рук. лаб., д-р биол. наук, отд. вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

Zh A Berdygulova

НИИ экспериментальной медицины СЗО РАМН

студент-магистр, отд. вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

Natal'ya Valentinovna Larionova

НИИ экспериментальной медицины СЗО РАМН

Email: vnvlarionova@mail.ru
вед. науч. сотр., канд. биол. наук, отд. вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

Larisa Georgievna Rudenko

НИИ экспериментальной медицины СЗО РАМН

Email: vaccine@mail.ru
рук. отд., д-р мед. наук, проф., отдел вирусологии им. акад. А. А. Смородинцева; НИИ экспериментальной медицины СЗО РАМН

I A Dubrovina

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

E A Bazhenova

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

I V Kiseleva

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Zh A Berdygulova

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

N V Larionova

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

L G Rudenko

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences

References

  1. Александрова Г. И., Климов А. И. Живая вакцина против гриппа. - СПб., 1994.
  2. Правила лабораторной практики. Приказ Минздрава РФ № 708н от 23.08.2010. http://www.rg.ru/2010/10/22/laboratornaya-praktika-dok.html
  3. Чего больше от вакцинации - пользы или вреда? // Электронное периодическое издание "РИАН. Ру" от 13.10.2006. http://www.rian.ru/society/20061013/54786587.html.
  4. Kiseleva I., Klimov A., Su Q. et al. Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature sensitive phenotype of reassortant influenza A viruses, // Proceedings of "Options for the Control of Influenza V". Okinawa, Japan, 7-11 Oct., 2003 // Ed. Y. Kawaoka. - Amsterdam, 2004. - P. 547-550.
  5. Lin Y. P., Gregory V., Bennett M., Hay A. Recent changes among human influenza viruses // Virus Res. - 2004. - Vol. 103, N 1-2. - P. 47-52.
  6. Lowen A. C., Mubareka S., Tumpey T. M. et al. The guinea pig as a transmission model for human influenza viruses // Proc. Natl Acad. Sci. USA. - 2006. - Vol. 103, N 26. - P. 9988- 9992.
  7. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus // Nature. - 2009. - Vol. 459, N 7249. - P. 931-939.
  8. Padlan E. A. The pandemic 2009 (H1N1) swine influenza virus is mild compared to the pandemic 1918 (H1N1) virus because of a proline-to-serine substitution in the receptor-binding site of its hemagglutinin - a hypothesis // Med. Hypothes. - 2010. - Vol. 74, N 2. - P. 240-241.
  9. Parks C. L., Latham T., Cahill A. et al. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain // Virology. - 2007. - Vol. 367. - P. 275-287.
  10. Vesikari T., Karvonen A., Korhonen T. et al. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine // Pediatr. Infect. Dis. J. - 2006. - Vol. 25, N 7. - P. 590-595.
  11. WHO. Initiative for Vaccine Research (IVR). Options for Live Attenuated Influenza Vaccines (LAIV) In the Control of Epidemic and Pandemic Influenza 12-13 June 2007. http:// www.who.int/vaccine_research/diseases/influenza/ meeting_120707/en/index.html.
  12. WHO. Global alert and response (GAR). Confirmed Human Cases of Avian Influenza A (H5N1). http://www.who.int/csr/ disease/avian_influenza/country/en/.

Copyright (c) 2011 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies